Follow
Jeanette Bowles
Jeanette Bowles
Research scientist, UBC, BCCSU
Verified email at bccsu.ubc.ca
Title
Cited by
Cited by
Year
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study
C Russell, F Ali, F Nafeh, J Rehm, S LeBlanc, T Elton-Marshall
Journal of substance abuse treatment 129, 108374, 2021
1012021
Post-overdose interventions triggered by calling 911: Centering the perspectives of people who use drugs (PWUDs)
KD Wagner, RW Harding, R Kelley, B Labus, SR Verdugo, E Copulsky, ...
PloS one 14 (10), e0223823, 2019
792019
Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications
JM Bowles, K McDonald, N Maghsoudi, H Thompson, C Stefan, ...
Harm reduction journal 18, 1-6, 2021
482021
“I Gotta Go With Modern Technology, So I’m Gonna Give’em the Narcan”: the diffusion of innovations and an opioid overdose prevention program
JM Bowles, SE Lankenau
Qualitative health research 29 (3), 345-356, 2019
322019
Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips
MK Reed, NS Imperato, JM Bowles, VJ Salcedo, A Guth, KL Rising
Drug and alcohol dependence reports 4, 100074, 2022
282022
“Generally, you get 86′ ed because you're a liability”: An application of Integrated Threat Theory to frequently witnessed overdoses and social distancing responses
JM Bowles, LR Smith, SR Verdugo, KD Wagner, PJ Davidson
Social Science & Medicine 260, 113190, 2020
262020
Overdose prevention and housing: a qualitative study examining drug use, overdose risk, and access to safer supply in permanent supportive housing in Vancouver, Canada
A Ivsins, L MacKinnon, JM Bowles, A Slaunwhite, G Bardwell
Journal of urban health 99 (5), 855-864, 2022
232022
Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada
N Maghsoudi, J Bowles, D Werb
Canadian Journal of Public Health 111 (4), 606-609, 2020
232020
Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities
TL Gaines, KD Wagner, ML Mittal, JM Bowles, E Copulsky, M Faul, ...
Drug and alcohol dependence 213, 108084, 2020
162020
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis
M Karamouzian, B Rafat, G Kolla, K Urbanoski, K Atkinson, G Bardwell, ...
International Journal of Drug Policy 120, 104157, 2023
112023
“I wanted to close the chapter completely… and I feel like that [carrying naloxone] would keep it open a little bit”: Refusal to carry naloxone among newly-abstinent opioid …
JM Bowles, LR Smith, ML Mittal, RW Harding, E Copulsky, G Hennessy, ...
International Journal of Drug Policy 94, 103200, 2021
112021
Factors associated with calling 911 for an overdose: an ethnographic decision tree modeling approach
KD Wagner, B Koch, JM Bowles, SR Verdugo, RW Harding, PJ Davidson
American journal of public health 111 (7), 1281-1283, 2021
112021
“We’re already doing this work”: ethical research with community-based organizations
R Fielding-Miller, S Kim, J Bowles, S Streuli, P Davidson
BMC medical research methodology 22 (1), 237, 2022
92022
Drug checking use and interest among people who inject drugs in Toronto, Canada
I Rammohan, Z Bouck, S Fusigboye, J Bowles, K McDonald, ...
International Journal of Drug Policy 107, 103781, 2022
82022
Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City
AS Bennett, J Scheidell, JM Bowles, M Khan, A Roth, L Hoff, C Marini, ...
Harm reduction journal 19 (1), 20, 2022
72022
Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
G Bardwell, JM Bowles, M Mansoor, D Werb, T Kerr
Substance abuse treatment, prevention, and policy 18 (1), 14, 2023
62023
Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada
KM Scarfone, N Maghsoudi, K McDonald, H Thompson, C Stefan, ...
Clinical Toxicology 60 (8), 979-984, 2022
42022
Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico
JM Bowles, S Jain, X Sun, SA Strathdee, K DeBeck, MJ Milloy, Z Bouck, ...
International Journal of Drug Policy 95, 103398, 2021
42021
Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic
JM Bowles, G Kolla, LR Smith, A Scheim, Z Dodd, D Werb
Drug and Alcohol Dependence Reports 7, 100167, 2023
32023
Media framing xylazine as a “zombie drug” is amplifying stigma onto people who use drugs
JM Bowles, EC Copulsky, MK Reed
International Journal of Drug Policy 125, 104338, 2024
22024
The system can't perform the operation now. Try again later.
Articles 1–20